tirzepatide update today FDA says shortage of GLP-1 is over FDA approval for Zepbound (tirzepatide)

however, this would need to be proven through additional research, he notes

Patients should be counseled on: Adequate hydration to prevent dehydration from vomiting or diarrhea Recognition of severe abdominal pain that could indicate pancreatitis (rare but serious adverse effect) Strategies to manage nausea, including eating smaller meals and avoiding high-fat foods Pregnancy and lactation : Tirzepatide should be discontinued if pregnancy is recognized

"We have created something truly unique in the healthcare ecosystem," said Ann Bilyew, SVP, Health and Group GM, WebMD Ignite

However, it is common for older people to have some level of B12 deficiency